Magellan Rx Management introduced a program to educate patients, clients and health care providers on clinical, financial and regulatory facts about biosimilar oncology drugs.
PBM to educate patients, providers on oncology biosimilars
Sign up for PCMA SmartBrief
Top news for PBMs
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.